Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.
Int J Neuropsychopharmacol
; 25(2): 128-135, 2022 02 11.
Article
in En
| MEDLINE
| ID: mdl-34622272
Full text:
1
Database:
MEDLINE
Main subject:
Schizophrenia
/
Superoxide Dismutase
/
Antipsychotic Agents
/
Risperidone
/
Brain-Derived Neurotrophic Factor
/
Cognitive Dysfunction
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Int J Neuropsychopharmacol
Journal subject:
NEUROLOGIA
/
PSICOFARMACOLOGIA
Year:
2022
Type:
Article
Affiliation country:
China